Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Oct 1;153(10):1061-1063.
doi: 10.1001/jamadermatol.2017.2529.

Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial

Janneke Kessels  1   2 , Lotte Voeten  1   3 , Patty Nelemans  4 , Jack Cleutjens  5   6 , Lisa Maria Hillen  2   5 , Klara Mosterd  1   2 , Nicole W J Kelleners-Smeets  1   2
Affiliations
Randomized Controlled Trial

Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial

Janneke Kessels et al. JAMA Dermatol. .

Abstract

This randomized clinical trial compares topical sinecatechins ointment, 10%, vs placebo in the treatment of superficial basal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Immunohistochemical Analysis
This figure shows the proportion of patients with decreased Ki-67 and Bcl-2 expression after treatment, compared with baseline.
Figure 2.
Figure 2.. Local Adverse Events
This figure shows the percentage of patients with moderate to severe local skin reactions during treatment for the sinecatechins, 10%, and placebo groups.
See this image and copyright information in PMC

References

    1. Singh T, Katiyar SK. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling. Toxicol Appl Pharmacol. 2013;273(2):418-424. - PMC - PubMed
    1. Roop D, Toftgård R. Hedgehog in Wnterland. Nat Genet. 2008;40(9):1040-1041. - PubMed
    1. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5(12):997-1014. - PubMed
    1. Vidal D, Matías-Guiu X, Alomar A. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis. Br J Dermatol. 2004;151(3):656-662. - PubMed
    1. Brinkhuizen T, Frencken KJ, Nelemans PJ, et al. . The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): a phase II, randomized controlled trial. J Am Acad Dermatol. 2016;75(1):126-134. - PubMed

Publication types

MeSH terms